Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Conducting CIP (Clean in Place) in Machines – V 2.0

Posted on By

SOP for Conducting CIP (Clean in Place) in Machines – V 2.0

Procedure for Conducting CIP (Clean in Place) in Machines

Department Production/Engineering/Quality Assurance (QA)
SOP No. SOP/Ointment/047
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic process for conducting Clean-In-Place (CIP) in manufacturing machines used in ointment production. Proper CIP ensures equipment cleanliness, prevents contamination, and maintains GMP compliance.

2. Scope

This SOP applies to all personnel responsible for handling, operating, and maintaining CIP systems in ointment manufacturing equipment.

3. Responsibilities

  • Production Supervisor: Ensures CIP is performed as per schedule.
  • Machine Operator: Initiates and monitors the CIP cycle.
  • Quality Assurance (QA) Personnel: Verifies cleanliness and maintains records.
  • Engineering Technician: Conducts preventive and corrective maintenance on CIP systems.

4. Accountability

The Production and QA Managers are accountable for ensuring that CIP operations comply with GMP standards and are properly documented.

See also  Ointments: SOP for Performing Rinse Sampling for Validation - V 2.0

5. Procedure

5.1 Pre-CIP Preparations

  • Ensure that the machine is empty and free from product residue.
  • Verify that the cleaning solution and water supply are sufficient for the CIP cycle.
  • Ensure that all valves, hoses, and drain outlets are properly connected.

5.2 Selecting the CIP Cycle

  • Choose the appropriate CIP cycle based on equipment type and residue level:
    • Single-Pass CIP: Suitable for low-contamination equipment.
    • Recirculating
CIP: Used for heavily contaminated equipment.
  • Final Rinse CIP: Ensures removal of residual cleaning agents.
  • 5.3 Conducting the CIP Process

    5.3.1 Pre-Rinse

    • Flush the system with purified water at 40°C–50°C.
    • Continue rinsing until all visible residues are removed.

    5.3.2 Cleaning Solution Circulation

    • Circulate an approved cleaning solution (e.g., sodium hydroxide 1%) at 60°C–80°C.
    • Maintain circulation for a minimum of 20 minutes.
    • Check for complete dissolution of residues.

    5.3.3 Intermediate Rinse

    • Flush the system with purified water to remove cleaning agent residues.
    • Verify the pH of the rinse water to confirm neutralization.

    5.3.4 Final Sanitization

    • Circulate a sanitizing agent (e.g., 70% ethanol or peracetic acid solution) for 10 minutes.
    • Ensure the sanitizer reaches all contact surfaces.

    5.3.5 Final Rinse

    • Perform a final rinse with purified water until no cleaning agent residues remain.
    • Collect and test rinse samples to ensure compliance with cleaning validation.

    5.4 Post-CIP Checks

    • Inspect the equipment for any remaining residues.
    • Verify conductivity, pH, and microbial limits of the final rinse water.
    • Document all parameters in the CIP Log.

    5.5 Cleaning Validation

    • QA must verify and approve the cleaned equipment before production restart.
    • Perform periodic swab testing to confirm the absence of contaminants.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • CIP – Clean-In-Place
    • BMR – Batch Manufacturing Record

    7. Documents

    • CIP Log (Annexure-1)
    • Cleaning Validation Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • 21 CFR Part 211 – Current Good Manufacturing Practices
    • ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: CIP Log

    Date Equipment ID CIP Cycle Type Cleaning Solution Used Final Rinse pH Verified By
    01/02/2025 CIP-101 Recirculating Sodium Hydroxide 1% 7.0 QA Officer
    02/02/2025 CIP-102 Single-Pass Peracetic Acid 0.2% 6.8 QA Officer

    Annexure-2: Cleaning Validation Report

    Date Equipment ID Swab Test Result Microbial Limits Final Status Approved By
    01/02/2025 CIP-101 Pass Within Limit Approved QA Head
    02/02/2025 CIP-102 Pass Within Limit Approved QA Head

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    See also  Ointments: SOP for Accelerated Stability Testing of Ointments - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: SOP for Compatibility Studies Between API and Excipients
    Next Post: SOP for Use of Design of Experiments (DoE) in Formulation Screening

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version